Jennifer Asmar

Papers

Total Citations

H-Index

About

Jennifer Asmar is a leading figure in gynecologic oncology and minimally invasive surgery, with a career dedicated to advancing surgical outcomes for women with complex reproductive and oncologic conditions. Her research centers on two pivotal areas: the refinement of robotic-assisted myomectomy for fibroid management and the strategic role of secondary cytoreductive surgery in recurrent ovarian cancer. Asmar’s major contribution lies in critically evaluating the safety and efficacy of robotic myomectomy, as demonstrated in her most-cited work, “Myomectomy by Robotically Assisted Laparoscopic Surgery: Results at Foch Hospital, Paris” (2015, 22 citations). This retrospective study provided early, real-world evidence on short- and long-term outcomes, comparing her team’s results with existing literature to highlight the procedure’s advantages and limitations—a foundational piece for surgeons adopting robotic techniques. In ovarian cancer, her 2019 paper, “The place of secondary complete cytoreductive surgery in advanced ovarian cancer” (5 citations), addresses a pressing clinical challenge: managing relapse after optimal treatment. By advocating for surgery’s growing legitimacy over chemotherapy alone in late relapse, Asmar contributes to a paradigm shift in care. Her work, rooted in the Department of Obstetrics and Gynecology at Foch Hospital, Paris, underscores a commitment to evidence-based, patient-centered innovation, making her a trusted voice in the field.